Question 1

Does Saba Capital Management own STLN stock?

Accepted Answer

No. Saba Capital Management exited its STLN (Starling Oncology) position in Q3 2025. Its Q2 2025 13F listed 94,264 shares worth $193,241.

Question 2

How many shares of STLN does Saba Capital Management own?

Accepted Answer

None since Q3 2025, when Saba Capital Management exited the position. Its Q2 2025 13F listed 94,264 shares worth $193,241.

Question 3

What is Saba Capital Management's STLN position worth?

Accepted Answer

Saba Capital Management's STLN position was worth $193,241 in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Saba Capital Management buying or selling STLN?

Accepted Answer

In Q3 2025, Saba Capital Management exited its entire STLN position.

Question 5

When did Saba Capital Management first buy STLN?

Accepted Answer

Saba Capital Management first reported STLN in its Q4 2021 13F and listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$3.49
2025-Q2	Unchanged	94,264	0.0%	$193,241	0.0%	$2.05
2025-Q1	Unchanged	94,264	0.0%	$107,461	0.0%	$1.14
2024-Q4	Unchanged	94,264	0.0%	$29,128	0.0%	$0.31
2024-Q3	Unchanged	94,264	0.0%	$30,815	0.0%	$0.33